Taka-Aki Hirose
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Taka-Aki Hirose has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Hidetaka Arimura
Division of Medical Quantum Science, Department of Health Sciences, Faculty of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan
3 shared publications Tadamasa Yoshitake
Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
3 shared publicationsYoshiyuki Shioyama
Affiliation Ion Beam Therapy Center, SAGA HIMAT Foundation, Tosu, Saga, Japan
3 shared publicationsSaiji Ohga
Department of Clinical Oncology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan
2 shared publications- Hideaki Hirashima
Department of Radiation Oncology and Image‐applied therapy Graduate School of Medicine Kyoto University Kyoto Japan
1 shared publication Hideaki Ikoma
Department of Radiation Technology, Ibaraki Prefectual Central Hospital, Kasama, Ibaraki, Japan
1 shared publication
Latest Publications
- Open Access
- 25 June 2025
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 35, 100321
Dosimetric evaluation of cone beam computed tomography-guided online adaptive radiotherapy in gastric mucosa-associated lymphoid tissue lymphoma
- 25 June 2025
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 35, 100321
Open AccessDosimetric evaluation of cone beam computed tomography-guided online adaptive radiotherapy in gastric mucosa-associated lymphoid tissue lymphoma
- 25 July 2022
- Published by Elsevier in Brachytherapy
- Vol. 21 (6) , 956-967
Multi-Institutional Study of End-to-End Dose Delivery Quality Assurance Testing for Image-Guided Brachytherapy Using a Gel Dosimeter
- 25 July 2022
- Published by Elsevier in Brachytherapy
- Vol. 21 (6) , 956-967
Multi-Institutional Study of End-to-End Dose Delivery Quality Assurance Testing for Image-Guided Brachytherapy Using a Gel Dosimeter
- Open Access
- 31 January 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (1) , e0263292
Synergistic combination of a topologically invariant imaging signature and a biomarker for the accurate prediction of symptomatic radiation pneumonitis before stereotactic ablative radiotherapy for lung cancer: A retrospective analysis
Objectives: We aimed to explore the synergistic combination of a topologically invariant Betti number (BN)-based signature and a biomarker for the accurate prediction of symptomatic (grade ≥2) radiation-induced pneumonitis (RP+) before stereotactic ablative radiotherapy (SABR) for lung cancer. Methods: A total of 272 SABR cases with early-stage non-small cell lung cancer were chosen for this study. The occurrence of RP+ was predicted using a support vector machine (SVM) model trained with the combined features of the BN-based signature extracted from planning computed tomography (pCT) images and a pretreatment biomarker, serum Krebs von den Lungen-6 (BN+KL-6 model). In all, 242 (20 RP+ and 222 RP–(grade 1)) and 30 cases (8 RP+ and 22 RP–) were used for training and testing the model, respectively. The BN-based features were extracted from BN maps that characterize topologically invariant heterogeneous traits of potential RP+ lung regions on pCT images by applying histogram- and texture-based feature calculations to the maps. The SVM models were built to predict RP+ patients with a BN signature that was constructed based on the least absolute shrinkage and selection operator logistic regression model. The evaluation of the prediction models was performed based on the area under the receiver operating characteristic curves (AUCs) and accuracy in the test. The performance of the BN+KL-6 model was compared to the performance based on the BN, conventional original pCT, and wavelet decomposition (WD) models. Results: The test AUCs obtained for the BN+KL-6, BN, pCT, and WD models were 0.825, 0.807, 0.642, and 0.545, respectively. The accuracies of the BN+KL-6, BN, pCT, and WD models were found to be 0.724, 0.708, 0.591, and 0.534, respectively. Conclusion: This study demonstrated the comprehensive performance of the BN+KL-6 model for the prediction of potential RP+ patients before SABR for lung cancer.
- 31 January 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (1) , e0263292
Open AccessSynergistic combination of a topologically invariant imaging signature and a biomarker for the accurate prediction of symptomatic radiation pneumonitis before stereotactic ablative radiotherapy for lung cancer: A retrospective analysis
Objectives: We aimed to explore the synergistic combination of a topologically invariant Betti number (BN)-based signature and a biomarker for the accurate prediction of symptomatic (grade ≥2) radiation-induced pneumonitis (RP+) before stereotactic ablative radiotherapy (SABR) for lung cancer. Methods: A total of 272 SABR cases with early-stage non-small cell lung cancer were chosen for this study. The occurrence of RP+ was predicted using a support vector machine (SVM) model trained with the combined features of the BN-based signature extracted from planning computed tomography (pCT) images and a pretreatment biomarker, serum Krebs von den Lungen-6 (BN+KL-6 model). In all, 242 (20 RP+ and 222 RP–(grade 1)) and 30 cases (8 RP+ and 22 RP–) were used for training and testing the model, respectively. The BN-based features were extracted from BN maps that characterize topologically invariant heterogeneous traits of potential RP+ lung regions on pCT images by applying histogram- and texture-based feature calculations to the maps. The SVM models were built to predict RP+ patients with a BN signature that was constructed based on the least absolute shrinkage and selection operator logistic regression model. The evaluation of the prediction models was performed based on the area under the receiver operating characteristic curves (AUCs) and accuracy in the test. The performance of the BN+KL-6 model was compared to the performance based on the BN, conventional original pCT, and wavelet decomposition (WD) models. Results: The test AUCs obtained for the BN+KL-6, BN, pCT, and WD models were 0.825, 0.807, 0.642, and 0.545, respectively. The accuracies of the BN+KL-6, BN, pCT, and WD models were found to be 0.724, 0.708, 0.591, and 0.534, respectively. Conclusion: This study demonstrated the comprehensive performance of the BN+KL-6 model for the prediction of potential RP+ patients before SABR for lung cancer.
- Open Access
- 24 November 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-9
Radiomic prediction of radiation pneumonitis on pretreatment planning computed tomography images prior to lung cancer stereotactic body radiation therapy
This study developed a radiomics-based predictive model for radiation-induced pneumonitis (RP) after lung cancer stereotactic body radiation therapy (SBRT) on pretreatment planning computed tomography (CT) images. For the RP prediction models, 275 non-small-cell lung cancer patients consisted of 245 training (22 with grade ≥ 2 RP) and 30 test cases (8 with grade ≥ 2 RP) were selected. A total of 486 radiomic features were calculated to quantify the RP texture patterns reflecting radiation-induced tissue reaction within lung volumes irradiated with more than x Gy, which were defined as LVx. Ten subsets consisting of all 22 RP cases and 22 or 23 randomly selected non-RP cases were created from the imbalanced dataset of 245 training patients. For each subset, signatures were constructed, and predictive models were built using the least absolute shrinkage and selection operator logistic regression. An ensemble averaging model was built by averaging the RP probabilities of the 10 models. The best model areas under the receiver operating characteristic curves (AUCs) calculated on the training and test cohort for LV5 were 0.871 and 0.756, respectively. The radiomic features calculated on pretreatment planning CT images could be predictive imaging biomarkers for RP after lung cancer SBRT.
- 24 November 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-9
Open AccessRadiomic prediction of radiation pneumonitis on pretreatment planning computed tomography images prior to lung cancer stereotactic body radiation therapy
This study developed a radiomics-based predictive model for radiation-induced pneumonitis (RP) after lung cancer stereotactic body radiation therapy (SBRT) on pretreatment planning computed tomography (CT) images. For the RP prediction models, 275 non-small-cell lung cancer patients consisted of 245 training (22 with grade ≥ 2 RP) and 30 test cases (8 with grade ≥ 2 RP) were selected. A total of 486 radiomic features were calculated to quantify the RP texture patterns reflecting radiation-induced tissue reaction within lung volumes irradiated with more than x Gy, which were defined as LVx. Ten subsets consisting of all 22 RP cases and 22 or 23 randomly selected non-RP cases were created from the imbalanced dataset of 245 training patients. For each subset, signatures were constructed, and predictive models were built using the least absolute shrinkage and selection operator logistic regression. An ensemble averaging model was built by averaging the RP probabilities of the 10 models. The best model areas under the receiver operating characteristic curves (AUCs) calculated on the training and test cohort for LV5 were 0.871 and 0.756, respectively. The radiomic features calculated on pretreatment planning CT images could be predictive imaging biomarkers for RP after lung cancer SBRT.
- Open Access
- 20 January 2020
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 21 (2) , 73-81
Observer uncertainties of soft tissue‐based patient positioning in IGRT
Purpose There remain uncertainties due to inter‐ and intraobserver variability in soft‐tissue‐based patient positioning even with the use of image‐guided radiation therapy (IGRT). This study aimed to reveal observer uncertainties of soft‐tissue‐based patient positioning on cone‐beam computed tomography (CBCT) images for prostate cancer IGRT. Methods Twenty‐six patients (7–8 fractions/patient, total number of 204 fractions) who underwent IGRT for prostate cancer were selected. Six radiation therapists retrospectively measured prostate cancer location errors (PCLEs) of soft‐tissue‐based patient positioning between planning CT (pCT) and pretreatment CBCT (pre‐CBCT) images after automatic bone‐based registration. Observer uncertainties were evaluated based on residual errors, which denoted the differences between soft‐tissue and reference positioning errors. Reference positioning errors were obtained as PCLEs of contour‐based patient positioning between pCT and pre‐CBCT images. Intraobserver variations were obtained from the difference between the first and second soft‐tissue‐based patient positioning repeated by the same observer for each fraction. Systematic and random errors of inter‐ and intraobserver variations were calculated in anterior–posterior (AP), superior–inferior (SI), and left–right (LR) directions. Finally, clinical target volume (CTV)‐to‐planning target volume (PTV) margins were obtained from systematic and random errors of inter‐ and intraobserver variations in AP, SI, and LR directions. Results Interobserver variations in AP, SI, and LR directions were 0.9, 0.9, and 0.5 mm, respectively, for the systematic error, and 1.8, 2.2, and 1.1 mm, respectively, for random error. Intraobserver variations were <0.2 mm in all directions. CTV‐to‐PTV margins in AP, SI, and LR directions were 3.5, 3.8, and 2.1 mm, respectively. Conclusion Intraobserver variability was sufficiently small and would be negligible. However, uncertainties due to interobserver variability for soft‐tissue‐based patient positioning using CBCT images should be considered in CTV‐to‐PTV margins.
- 20 January 2020
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 21 (2) , 73-81
Open AccessObserver uncertainties of soft tissue‐based patient positioning in IGRT
Purpose There remain uncertainties due to inter‐ and intraobserver variability in soft‐tissue‐based patient positioning even with the use of image‐guided radiation therapy (IGRT). This study aimed to reveal observer uncertainties of soft‐tissue‐based patient positioning on cone‐beam computed tomography (CBCT) images for prostate cancer IGRT. Methods Twenty‐six patients (7–8 fractions/patient, total number of 204 fractions) who underwent IGRT for prostate cancer were selected. Six radiation therapists retrospectively measured prostate cancer location errors (PCLEs) of soft‐tissue‐based patient positioning between planning CT (pCT) and pretreatment CBCT (pre‐CBCT) images after automatic bone‐based registration. Observer uncertainties were evaluated based on residual errors, which denoted the differences between soft‐tissue and reference positioning errors. Reference positioning errors were obtained as PCLEs of contour‐based patient positioning between pCT and pre‐CBCT images. Intraobserver variations were obtained from the difference between the first and second soft‐tissue‐based patient positioning repeated by the same observer for each fraction. Systematic and random errors of inter‐ and intraobserver variations were calculated in anterior–posterior (AP), superior–inferior (SI), and left–right (LR) directions. Finally, clinical target volume (CTV)‐to‐planning target volume (PTV) margins were obtained from systematic and random errors of inter‐ and intraobserver variations in AP, SI, and LR directions. Results Interobserver variations in AP, SI, and LR directions were 0.9, 0.9, and 0.5 mm, respectively, for the systematic error, and 1.8, 2.2, and 1.1 mm, respectively, for random error. Intraobserver variations were <0.2 mm in all directions. CTV‐to‐PTV margins in AP, SI, and LR directions were 3.5, 3.8, and 2.1 mm, respectively. Conclusion Intraobserver variability was sufficiently small and would be negligible. However, uncertainties due to interobserver variability for soft‐tissue‐based patient positioning using CBCT images should be considered in CTV‐to‐PTV margins.
- 1 October 2018
- Published by Elsevier in Physica Medica
- Vol. 54, 66-76
Effect of accounting for interfractional CTV shape variations in PTV margins on prostate cancer radiation treatment plans
- 1 October 2018
- Published by Elsevier in Physica Medica
- Vol. 54, 66-76
Effect of accounting for interfractional CTV shape variations in PTV margins on prostate cancer radiation treatment plans